ODTX
Odyssey Therapeutics, Inc.
20.99
+0.99 (+4.95%)
52w low 15.10
29.05 high
42.2% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 1.04M | 4.47M | 2.98M | |
| Operating Expenses | 122.78M | 134.48M | 139.69M | 164.13M | |
| R&D | 101.75M | 112.28M | 112.58M | 126.62M | |
| SG&A | 21.02M | 22.20M | 27.12M | 37.52M | |
| Operating Income | -122.78M | -133.44M | -135.22M | -161.16M | |
| EBITDA | -121.26M | -120.25M | -123.64M | -144.65M | |
| Pretax Income | -124.32M | -125.49M | -128.85M | -149.57M | |
| Income Tax | 347.00K | 447.00K | 469.00K | -927.00K | |
| Net Income | -124.67M | -125.94M | -129.32M | -148.65M | |
| EPS Diluted | -4.52 | -1.32 | -4.73 | -5.39 | |
| Diluted Shares | 27.56M | 99.23M | 27.56M | 27.56M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-33.5%